Lavomax 10s 125 mg coated tablets
- $51.50
The instruction for medical use
of medicine
Lavomax
A trade name
Lavomax
the International unlicensed
name Tiloron Lekarstvennaya
the Tablet form, coated 125 mg
Structure
One tablet contains
active agent tiloron 0.125 g,
excipients: magnesium carbonic the main water, kollidon, calcium stearate, sucrose, the titan dioxide, aerosil, tropeolin 0, polyethyleneglycol high-molecular (6000), beeswax, liquid paraffin, talc, before receiving a tablet weighing 0.39 g.
The description
of the Tablet, coated, from yellow till orange color, round shape. On cross section 2 layers are visible. Kernel of a tablet of orange color.
Pharmacotherapeutic group
Other antiviral drugs of direct action.
The code of automatic telephone exchange J05AX
The pharmacological
Pharmacokinetics Later properties of intake Lavomax is quickly soaked up from digestive tract. The bioavailability is 60%. About 80% of drug contact proteins of blood plasma.
Drug practically in not changed view with a stake (70%) and urine (9%) is removed. Elimination half-life (T1/2) makes 48 hours. Drug is not exposed to biotransformation and does not collect in an organism.
The pharmacodynamics
Lavomax stimulates education in an organism, and - interferon. The main producers of interferon in response to administration of Lavomax are intestines epithelium cells, hepatocytes, T lymphocytes and neutrophils. After intake at most of products of interferon intestines-liver-blood in 4-24 hours are defined in the sequence. Lavomax has immunomodulatory and antiviral effect. Stimulates stem cells of marrow, depending on a dose strengthens antibodyformation, reduces immunosuppression degree, restores a ratio T-helpery/T-supressory. It is effective against various viral infections, including against flu, other acute respiratory infections, hepatitis A and herpes. The mechanism of anti-virus action is connected with inhibition of broadcast of virus-specific proteins in the infected cells therefore the reproduction of viruses is suppressed.
Indications
At adults:
- a viral hepatitis And
- a herpes infection
- a Cytomegaloviral infection
- infectious and allergic and viral encephalomyelitis (multiple sclerosis, leukoencephalites, uveoentsefalita, etc.) as a part of complex therapy
- urogenital and respiratory clamidiosis, as a part of complex therapy
- treatment and prevention of flu and other acute respiratory viral infections (ARVI)
- a pulmonary tuberculosis, as a part of complex therapy, at the proved immune insufficiency.
At children 7 years are more senior:
- treatment of flu and other SARS.
The route of administration and doses
use Drug inside after a meal.
At adults:
For nonspecific prevention of a viral hepatitis And on 1 tablet (that corresponds to 125 mg of a tiloron) once a week within 6 weeks.
A course dose of 6 tablets on 125 mg (that corresponds to 750 mg of a tiloron).
For treatment of a viral hepatitis And the first day on 1 tablet (that corresponds to 125 mg of a tiloron) 2 times a day, then, on 1 tablet every 48 hours. A course dose of 10 tablets (that corresponds to 1.25 g of a tiloron).
At treatment of flu and other SARS in the first two days of a disease appoint on 1 tablet (that corresponds to 125 mg of a tiloron) a day, then, on 1 tablet (125 mg) every 48 hours. A course dose of 6 tablets (that corresponds to 750 mg of a tiloron).
For prevention of flu and other SARS appoint on 1 tablet of Lavomax (125 mg) once a week within 6 weeks (to a course of treatment of 6 tablets 125 mg).
For treatment of a herpes and Cytomegaloviral infection the first two days accept on 1 tablet of Lavomax (125 mg) a day, then, on 1 tablet (125 mg) every 48 hours. Course dose of 20 tablets of Lavomax (2.5 g).
In urogenital and respiratory clamidiosis the first two days accept on 1 tablet of Lavomax (that corresponds to 125 mg of a tiloron) a day, then, on 1 tablet (125 mg) every 48 hours. Course dose of 10 tablets of Lavomax (1.25 g).
As a part of complex therapy of neuroviral infections the dose is established individually. The course of treatment makes 4 weeks.
In a pulmonary tuberculosis the first two days accept 2 tablets (that corresponds to 250 mg of a tiloron) a day, then, on 1 tablet (125 mg) in each 48 h. A course dose of 20 tablets of Lavomax (2.5 g), within 36 days.
At children 7 years are more senior:
The first two days apply 60 mg of a tiloron a day to treatment of flu or other SARS, then, on 60 mg of a tiloron every 48 hours. The course dose makes 180 mg at uncomplicated forms of flu or other acute respiratory viral infections and 240 mg - at the complicated forms.
Side effects
- allergic reactions
- the dispeptic phenomena
- a short-term fever.
Contraindications
- hypersensitivity to drug components
- the period of pregnancy and a lactation
- children up to 7 years.
Medicinal interactions
Lavomax is compatible to antibiotics and means of traditional treatment of viral and bacterial diseases.
Clinically significant interaction of Lavomax with antibiotics and means of traditional treatment of viral and bacterial diseases is not revealed.
Special indications
of Feature of influence of medicine on ability to drive the car or potentially dangerous mechanisms
does not influence.
Overdose
Cases of overdose of Lavomax are unknown.
A form of release and packing
of the Tablet, coated 125 mg, on 6 or 10 tablets in the blister, 1 blister together with the instruction for use in a cardboard pack.
To Store storage conditions in the dry, protected from light place, at a temperature not higher than + 25C.
To store out of children's reach!
A period of storage
2 years
not to use drug after the expiry date specified on packing.
Prescription status
Without prescription
JSC Nizhpharm Producer,
Russia 603950, Nizhny Novgorod, GSP-459, Salganskaya St., 7
Ph.: (831) 278 80 88
Fax: (831) 430 72 28
Web website: http://www.nizhpharm.ru/
of medicine
Lavomax
A trade name
Lavomax
the International unlicensed
name Tiloron Lekarstvennaya
the Tablet form, coated 125 mg
Structure
One tablet contains
active agent tiloron 0.125 g,
excipients: magnesium carbonic the main water, kollidon, calcium stearate, sucrose, the titan dioxide, aerosil, tropeolin 0, polyethyleneglycol high-molecular (6000), beeswax, liquid paraffin, talc, before receiving a tablet weighing 0.39 g.
The description
of the Tablet, coated, from yellow till orange color, round shape. On cross section 2 layers are visible. Kernel of a tablet of orange color.
Pharmacotherapeutic group
Other antiviral drugs of direct action.
The code of automatic telephone exchange J05AX
The pharmacological
Pharmacokinetics Later properties of intake Lavomax is quickly soaked up from digestive tract. The bioavailability is 60%. About 80% of drug contact proteins of blood plasma.
Drug practically in not changed view with a stake (70%) and urine (9%) is removed. Elimination half-life (T1/2) makes 48 hours. Drug is not exposed to biotransformation and does not collect in an organism.
The pharmacodynamics
Lavomax stimulates education in an organism, and - interferon. The main producers of interferon in response to administration of Lavomax are intestines epithelium cells, hepatocytes, T lymphocytes and neutrophils. After intake at most of products of interferon intestines-liver-blood in 4-24 hours are defined in the sequence. Lavomax has immunomodulatory and antiviral effect. Stimulates stem cells of marrow, depending on a dose strengthens antibodyformation, reduces immunosuppression degree, restores a ratio T-helpery/T-supressory. It is effective against various viral infections, including against flu, other acute respiratory infections, hepatitis A and herpes. The mechanism of anti-virus action is connected with inhibition of broadcast of virus-specific proteins in the infected cells therefore the reproduction of viruses is suppressed.
Indications
At adults:
- a viral hepatitis And
- a herpes infection
- a Cytomegaloviral infection
- infectious and allergic and viral encephalomyelitis (multiple sclerosis, leukoencephalites, uveoentsefalita, etc.) as a part of complex therapy
- urogenital and respiratory clamidiosis, as a part of complex therapy
- treatment and prevention of flu and other acute respiratory viral infections (ARVI)
- a pulmonary tuberculosis, as a part of complex therapy, at the proved immune insufficiency.
At children 7 years are more senior:
- treatment of flu and other SARS.
The route of administration and doses
use Drug inside after a meal.
At adults:
For nonspecific prevention of a viral hepatitis And on 1 tablet (that corresponds to 125 mg of a tiloron) once a week within 6 weeks.
A course dose of 6 tablets on 125 mg (that corresponds to 750 mg of a tiloron).
For treatment of a viral hepatitis And the first day on 1 tablet (that corresponds to 125 mg of a tiloron) 2 times a day, then, on 1 tablet every 48 hours. A course dose of 10 tablets (that corresponds to 1.25 g of a tiloron).
At treatment of flu and other SARS in the first two days of a disease appoint on 1 tablet (that corresponds to 125 mg of a tiloron) a day, then, on 1 tablet (125 mg) every 48 hours. A course dose of 6 tablets (that corresponds to 750 mg of a tiloron).
For prevention of flu and other SARS appoint on 1 tablet of Lavomax (125 mg) once a week within 6 weeks (to a course of treatment of 6 tablets 125 mg).
For treatment of a herpes and Cytomegaloviral infection the first two days accept on 1 tablet of Lavomax (125 mg) a day, then, on 1 tablet (125 mg) every 48 hours. Course dose of 20 tablets of Lavomax (2.5 g).
In urogenital and respiratory clamidiosis the first two days accept on 1 tablet of Lavomax (that corresponds to 125 mg of a tiloron) a day, then, on 1 tablet (125 mg) every 48 hours. Course dose of 10 tablets of Lavomax (1.25 g).
As a part of complex therapy of neuroviral infections the dose is established individually. The course of treatment makes 4 weeks.
In a pulmonary tuberculosis the first two days accept 2 tablets (that corresponds to 250 mg of a tiloron) a day, then, on 1 tablet (125 mg) in each 48 h. A course dose of 20 tablets of Lavomax (2.5 g), within 36 days.
At children 7 years are more senior:
The first two days apply 60 mg of a tiloron a day to treatment of flu or other SARS, then, on 60 mg of a tiloron every 48 hours. The course dose makes 180 mg at uncomplicated forms of flu or other acute respiratory viral infections and 240 mg - at the complicated forms.
Side effects
- allergic reactions
- the dispeptic phenomena
- a short-term fever.
Contraindications
- hypersensitivity to drug components
- the period of pregnancy and a lactation
- children up to 7 years.
Medicinal interactions
Lavomax is compatible to antibiotics and means of traditional treatment of viral and bacterial diseases.
Clinically significant interaction of Lavomax with antibiotics and means of traditional treatment of viral and bacterial diseases is not revealed.
Special indications
of Feature of influence of medicine on ability to drive the car or potentially dangerous mechanisms
does not influence.
Overdose
Cases of overdose of Lavomax are unknown.
A form of release and packing
of the Tablet, coated 125 mg, on 6 or 10 tablets in the blister, 1 blister together with the instruction for use in a cardboard pack.
To Store storage conditions in the dry, protected from light place, at a temperature not higher than + 25C.
To store out of children's reach!
A period of storage
2 years
not to use drug after the expiry date specified on packing.
Prescription status
Without prescription
JSC Nizhpharm Producer,
Russia 603950, Nizhny Novgorod, GSP-459, Salganskaya St., 7
Ph.: (831) 278 80 88
Fax: (831) 430 72 28
Web website: http://www.nizhpharm.ru/
Related Products
Polysan (Russia)
Cycloferon® (Meglumine Acridonacetate) 150 mg x 10 Coated Tablets
$14.30
Out Of Stock
